Mar 24, 2016 by Brian FeroldiWhy Portola Pharmaceuticals Inc's Stock Is Bleeding Red TodayDisappointing results from a phase 3 trial have traders heading for the exits.
Mar 23, 2016 by Brian FeroldiWhy Bluebird Bio Inc. Plunged TodayBiotech stocks got kicked in the teeth on Wednesday, with Bluebird getting hit hard than most.
Mar 23, 2016 by Brian Feroldi, Sean Williams, and Daniel B. Kline3 Bargain Stocks You Can Buy TodayThese three stocks are cheap right now, but they may not stay that way for long.
Mar 21, 2016 by Brian FeroldiBiogen Inc. vs. Amgen: Which Big Biotech Is the Smarter Buy Today?Which of these two large-cap biotechs is the better choice for new money today?
Mar 20, 2016 by Brian Feroldi, Sean Williams, Brian Stoffel, Matt Frankel, CFP, and Cory Renauer5 Stocks All Retirees Should Consider BuyingThe average American who retires today at 65 will need their nest egg to last a couple of decades. Our Foolish contributors think these companies' stocks can help make that happen.
Mar 20, 2016 by Brian Feroldi, Brian Stoffel, and Rich Duprey3 Stocks Wall Street HatesShort-sellers are betting big against these three stocks.
Mar 20, 2016 by Brian Feroldi, Evan Niu, CFA, and Matt DiLalloIf You're in Your 30s, Consider Buying These StocksOur contributors think these three companies are solid choices for investors who have several decades to ride out the potential volatility as they grow.
Mar 19, 2016 by Brian FeroldiThis Was the Best Performing Healthcare ETF Last WeekHealthcare ETFs took another step back this week, but this one healthcare ETF largely sidestepped the carnage.
Mar 19, 2016 by Brian FeroldiHow Are Medicare Costs Calculated?If you're eligible to receive Medicare benefits, what will your costs look like?
Mar 18, 2016 by Brian Feroldi, Rich Duprey, and Demitri Kalogeropoulos3 Big Brand Stocks to Buy in MarchWhen companies' assets include iconic brands known the world over, you can expect they will reward patient shareholders for decades to come.
Mar 18, 2016 by Brian Feroldi, Evan Niu, CFA, and Daniel Miller3 Growth Dividend Stocks to Buy in MarchLooking to for stocks that can add both growth and income to you portfolio? Our contributors think that you should give these stocks a closer look.
Mar 18, 2016 by Brian Feroldi, Sean Williams, and Cheryl Swanson3 Biotech Stocks to Buy on SaleThe broader market has mostly rebounded from its early 2016 tumble. The biotech sector hasn't, and our contributors see some bargains available in it now.
Mar 15, 2016 by Brian FeroldiWhy MannKind Corporation Is Dropping TodayShares dropped after the company reported fourth-quarter earnings.
Mar 14, 2016 by Brian FeroldiHow to Suspend Your Social Security BenefitsAre you considering putting a temporary stop to your Social Security benefits? Here's what you need to know.
Mar 13, 2016 by Brian FeroldiThe Motley Fool Sits Down With the CEO of Dexcom Inc.In this hour-long interview, Motley Fool healthcare contributor Brian Feroldi asks a diabetes visionary about where his company is today and what kind of innovations are possible in the years ahead.
Mar 13, 2016 by Brian Feroldi, Evan Niu, CFA, and Jason Hall3 Things You Never Knew About Wall StreetImpressive your friends at your next cocktail party with these little-known facts about the storied street.
Mar 12, 2016 by Brian FeroldiLast Week's Best Healthcare ETFHealthcare stocks rallied during the week, but shareholders of this one ETF made out best.
Mar 11, 2016 by Brian FeroldiWhy Agenus Inc. Is Flying High TodayAn analyst upgrade sends shares higher.
Mar 11, 2016 by Brian FeroldiInstant Analysis: Regeneron Pharmaceuticals and Sanofi's Experimental Drug Bests an AbbVie BlockbusterShould AbbVie shareholders be concerend?
Mar 9, 2016 by Brian FeroldiInstant Analysis: Vertex Pharmaceuticals Inc Wins Another ApprovalThe company's newest cystic fibrosis drug has won approval in Australia, but can it move the needle?
